Dr. Robert Neil Mames, MD

Dr. Mames practices at HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare.

Dr. Mames' NPI, 1598747016, was assigned on November 18, 2005. Dr. Mames graduated from University Of Michigan Medical School in 1984. Dr. Mames holds Florida license ME0060348.

Dr. Mames' primary practice is HCA Florida North Florida Hospital, at 6500 W Newberry Rd, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 333-4100.

Dr. Mames' primary practice is HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare. Dmand AI also links Dr. Mames to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mames practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mames' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mames is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mames' licenses on file in 3 states: Florida, Massachusetts and Michigan.

Dmand AI lists age-related macular degeneration, cataract, glaucoma, inflammation of iris, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Mames treats.

CMS data shows 14,356 Medicare services from Dr. Mames across 15 procedure codes in 2024, for 706 Medicare patients. Medicare paid $840,653 for them. Every service was in an office.

CMS counts 706 Medicare patients who saw Dr. Mames in 2024. The largest group is 75 to 84, with 277 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mames' median patient age at 76, with 60% women.

In 2024, Dr. Mames wrote 30 Medicare Part D claims for 11 patients. 57% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $243 in total drug cost. In 2022, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mames for performance year 2024, reported as part of a group. Dr. Mames accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Mames, published from 2003 to 2011. The most frequent topics are Hematopoietic Stem Cells, Visual Acuity and Diabetic Retinopathy. Dr. Mames has published most often in Arch Ophthalmol. Dr. Mames' most frequent co-authors are Maria B. Grant, MD, Scott Mayer Friedman, MD and Curtis E. Margo, MD.

Dmand AI lists 1 award for Dr. Mames.

Dr. Mames graduated from University Of Michigan Medical School in 1984. Dr. Mames is a member of AAO.

Dr. Mames is in network with 10 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Aetna. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.